ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
5.87
+0.35 (6.34%)
At close: May 3, 2024, 4:00 PM
6.05
+0.18 (3.07%)
After-hours: May 3, 2024, 5:41 PM EDT

ClearPoint Neuro Revenue

In the year 2023, ClearPoint Neuro had annual revenue of $23.96M with 16.56% growth. Revenue in the quarter ending December 31, 2023 was $6.81M with 31.62% year-over-year growth.

Revenue (ttm)
$23.96M
Revenue Growth
+16.56%
P/S Ratio
6.61
Revenue / Employee
$223,879
Employees
107
Market Cap
158.35M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202323.96M3.40M16.56%
Dec 31, 202220.55M4.25M26.09%
Dec 31, 202116.30M3.47M27.05%
Dec 31, 202012.83M1.61M14.37%
Dec 31, 201911.22M3.86M52.54%
Dec 31, 20187.35M-26.26K-0.36%
Dec 31, 20177.38M1.63M28.35%
Dec 31, 20165.75M1.16M25.15%
Dec 31, 20154.59M989.71K27.46%
Dec 31, 20143.60M-326.09K-8.30%
Dec 31, 20133.93M-1.13M-22.29%
Dec 31, 20125.06M1.24M32.48%
Dec 31, 20113.82M1.15M43.03%
Dec 31, 20102.67M69.45K2.67%
Dec 31, 20092.60M650.00K33.33%
Dec 31, 20081.95M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Outset Medical 130.38M
InfuSystem Holdings 125.79M
Electromed 51.69M
Repare Therapeutics 51.13M
Biodesix 49.09M
Seer, Inc. 16.66M
Cardiff Oncology 610.00K
Revenue Rankings